Larimar Therapeutics Inc (LRMR) Wheel Strategy

Running a LRMR wheel strategy lets you generate consistent premium income on Larimar Therapeutics Inc while setting your own entry and exit prices on the underlying. Larimar Therapeutics Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own LRMR, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best LRMR wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on LRMR, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable LRMR wheel from a losing one.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the LRMR wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your LRMR wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.